Display Settings:

Format

Send to:

Choose Destination
    Proteomics Clin Appl. 2009 Jan;3(1):6-17. doi: 10.1002/prca.200800090. Epub 2008 Nov 20.

    Mass spectrometry in clinical proteomics - from the present to the future.

    Source

    Biomolecular Mass Sepctrometry Unit, Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.

    Abstract

    MS is an important analytical tool in clinical proteomics, primarily in the disease-specific discovery, identification and characterisation of proteomic biomarkers and patterns. MS-based proteomics is increasingly used in clinical validation and diagnostic method development. The latter departs from the typical application of MS-based proteomics by exchanging some of the high performance of analysis for the throughput, robustness and simplicity required for clinical diagnostics. Although conventional MS-based proteomics has become an important field in clinical applications, some of the most recent MS technologies have not yet been extensively applied in clinical proteomics. In this review, we will describe the current state of MS in clinical proteomics and look to the future of this field.

    Copyright © 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

    PMID:
    21136932
    [PubMed - in process]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk